A blood test that characterizes each prostate tumor by its unique genetic fingerprint may help pinpoint which men actually have prostate cancer, researchers say.
In a new study, the powerful genetic tool beat out standard PSA testing in discriminating between men who had cancer and those who did not, says Robert Ross, MD, of the Dana-Farber Cancer Institute in Boston.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
This article has:
- 1 view
Reactions to Gene Test May Predict Prostate Cancer
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account